Back to Directory

5-FU and Calcipotriol (Topical)

5-Fluorouracil and Calcipotriol, Topical Senolytic Combination

Visual ViewRaw Data
Combined Shape
Topical senolytic therapy to clear aged cells from the skin.

This is a combination topical therapy that acts as a potent senolytic, an agent that selectively destroys senescent (aged) cells. 5-Fluorouracil (5-FU), a chemotherapy drug, induces cell death in senescent cells, while calcipotriol, a vitamin D analog, enhances the local immune response to clear the resulting cellular debris. Its relevance to healthspan is as a targeted method to reduce the senescent cell burden in the skin, potentially mitigating local inflammation and improving tissue function.

Verdict

Promising topical senolytic for skin aging; systemic longevity benefits are unproven.

HEALTHSPAN IMPACT

Experimental

RISK LEVEL

High

EVIDENCE GRADE

B

MONTHLY COST

$100 - $300

Protocol

  • Apply a topical cream containing 0.005% calcipotriol and 5% 5-fluorouracil twice daily for 2-4 days.

Flags

  • This is an off-label use of prescription medications requiring a compounding pharmacy.
  • Causes significant skin irritation, redness, and peeling as part of its mechanism of action.
  • Systemic healthspan or longevity benefits beyond skin are currently speculative and unproven.
  • Should not be used by pregnant women or on open wounds.
  • Requires a prescription and strict medical supervision.